Fundraising FoxCutanos
Vienna, AT · 2 known investors
Find your way into Cutanos
Sign up to see every warm intro you have to Cutanos
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Cutanos team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Cutanos is a biotechnology company developing a Langerhans Cell Targeted Delivery System (LC-TDS) that uses a langerin-specific glycomimetic ligand to direct lipid nanoparticle and mRNA/protein formulations to specific skin-resident dendritic cells for vaccines and immunotherapies. The platform is administered via minimally invasive microneedles or microinjectors and targets next-generation vaccines, cancer immunotherapy, and autoimmune disease applications.
Founders & leadership
Investors · 2
In the news
Frequently asked questions
- What does Cutanos do?
- Cutanos is a biotechnology company developing a Langerhans Cell Targeted Delivery System (LC-TDS) that uses a langerin-specific glycomimetic ligand to direct lipid nanoparticle and mRNA/protein formulations to specific skin-resident dendritic cells for vaccines and immunotherapies. The platform is administered via minimally invasive microneedles or microinjectors and targets next-generation vaccines, cancer immunotherapy, and autoimmune disease applications.
- Who founded Cutanos?
- Cutanos was founded by Christoph Rademacher, Robert Wawrzinek.
- Who are Cutanos's investors?
- Cutanos's investors include xista science ventures, Khanu.
- Where is Cutanos headquartered?
- Cutanos is headquartered in Vienna, AT.